Product
KN026 + KN046
1 clinical trial
1 indication
Indication
HER2-positive solid tumorClinical trial
A Phase Ib Study to Evaluate Efficacy, Safety and Tolerability of KN026 Combined With KN046 in Subjects With HER2 Positive Solid TumorStatus: Completed, Estimated PCD: 2022-09-22